Haotian Xie, Zhenghua Cai, Qi Li, Jun Chen, Ying Li, Jingjing Ji, Yudong Qiu
{"title":"一种无创人工智能模型预测胰腺内神经周围浸润严重程度。","authors":"Haotian Xie, Zhenghua Cai, Qi Li, Jun Chen, Ying Li, Jingjing Ji, Yudong Qiu","doi":"10.1159/esr/actag002","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Intrapancreatic perineural invasion (IPNI) was a poor prognostic factor in pancreatic ductal adenocarcinoma (PDAC), but few studies quantified the severity of IPNI. Additionally, there was an absence of non-invasive tool to predicted IPNI.</p><p><strong>Methods: </strong>Patients who underwent radical pancreatectomy betweem 2018 and 2022 were enrolled. Severity of IPNI was assessed via binary classification, numeration, and neural invasion (NI) severity score. Cox regression analysis was performed to clarify the relationship between IPNI and prognosis. Clinical data, artificial intelligence (AI) , and radiomics were used to develop predictive models, evaluated by receiver operating characteristics (ROC) curve and decision curve analysis (DCA). Kaplan-Meier analysis confirmed the model's clinical utility.</p><p><strong>Results: </strong>A total of 192 patients were enrolled and rate of IPNI was 93.8%. Cox regression analysis and ROC curve indicated NI severity score>10.5 was responsible for poor prognosis (p<0.05). Further analysis indicated the AI model had better performance in predicting NI severity score>10.5 in both training set (clinical model AUC=0.66, AI model AUC=0.85, radiomics model AUC=0.81) and validation set (clinical model AUC=0.74, AI model AUC=0.84, radiomics model AUC=0.73). According to the predictive results of AI model, patient with NI severity score>10.5 had decreased recurrence free survival(RFS) and overall survival(OS) in training set (RFS 12months vs. 24 months, p=0.002; OS 24 months vs. 35 months, p=0.024) and validation set (RFS 8 months vs. 16 months, p=0.03; OS 25 months vs. 36 months, p=0.04).</p><p><strong>Conclusions: </strong>NI severity score >10.5 predicted poor PDAC prognosis, and AI was an useful tool to predict it.</p>","PeriodicalId":12222,"journal":{"name":"European Surgical Research","volume":" ","pages":"1"},"PeriodicalIF":2.5000,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A non-invasive artificial intelligence model to predict the severity of intrapancreatic perineural invasion.\",\"authors\":\"Haotian Xie, Zhenghua Cai, Qi Li, Jun Chen, Ying Li, Jingjing Ji, Yudong Qiu\",\"doi\":\"10.1159/esr/actag002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Intrapancreatic perineural invasion (IPNI) was a poor prognostic factor in pancreatic ductal adenocarcinoma (PDAC), but few studies quantified the severity of IPNI. Additionally, there was an absence of non-invasive tool to predicted IPNI.</p><p><strong>Methods: </strong>Patients who underwent radical pancreatectomy betweem 2018 and 2022 were enrolled. Severity of IPNI was assessed via binary classification, numeration, and neural invasion (NI) severity score. Cox regression analysis was performed to clarify the relationship between IPNI and prognosis. Clinical data, artificial intelligence (AI) , and radiomics were used to develop predictive models, evaluated by receiver operating characteristics (ROC) curve and decision curve analysis (DCA). Kaplan-Meier analysis confirmed the model's clinical utility.</p><p><strong>Results: </strong>A total of 192 patients were enrolled and rate of IPNI was 93.8%. Cox regression analysis and ROC curve indicated NI severity score>10.5 was responsible for poor prognosis (p<0.05). Further analysis indicated the AI model had better performance in predicting NI severity score>10.5 in both training set (clinical model AUC=0.66, AI model AUC=0.85, radiomics model AUC=0.81) and validation set (clinical model AUC=0.74, AI model AUC=0.84, radiomics model AUC=0.73). According to the predictive results of AI model, patient with NI severity score>10.5 had decreased recurrence free survival(RFS) and overall survival(OS) in training set (RFS 12months vs. 24 months, p=0.002; OS 24 months vs. 35 months, p=0.024) and validation set (RFS 8 months vs. 16 months, p=0.03; OS 25 months vs. 36 months, p=0.04).</p><p><strong>Conclusions: </strong>NI severity score >10.5 predicted poor PDAC prognosis, and AI was an useful tool to predict it.</p>\",\"PeriodicalId\":12222,\"journal\":{\"name\":\"European Surgical Research\",\"volume\":\" \",\"pages\":\"1\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2026-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Surgical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/esr/actag002\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Surgical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/esr/actag002","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
摘要
胰腺内神经周围浸润(IPNI)是胰腺导管腺癌(PDAC)预后不良的因素,但很少有研究量化IPNI的严重程度。此外,缺乏预测IPNI的非侵入性工具。方法:纳入2018年至2022年间行根治性胰腺切除术的患者。通过二元分类、计数和神经侵犯(NI)严重程度评分来评估IPNI的严重程度。采用Cox回归分析明确IPNI与预后的关系。利用临床数据、人工智能(AI)和放射组学建立预测模型,并通过受试者工作特征(ROC)曲线和决策曲线分析(DCA)进行评估。Kaplan-Meier分析证实了该模型的临床实用性。结果:共纳入192例患者,IPNI率为93.8%。Cox回归分析和ROC曲线显示,NI严重程度评分b> 10.5分与预后不良有关(训练集(临床模型AUC=0.66,人工智能模型AUC=0.85,放射组学模型AUC=0.81)和验证集(临床模型AUC=0.74,人工智能模型AUC=0.84,放射组学模型AUC=0.73)均为p10.5分。根据AI模型的预测结果,NI严重程度评分>10.5的患者在训练集(RFS 12个月vs 24个月,p=0.002; OS 24个月vs 35个月,p=0.024)和验证集(RFS 8个月vs 16个月,p=0.03; OS 25个月vs 36个月,p=0.04)的无复发生存期(RFS)和总生存期(OS)均有所降低。结论:NI严重程度评分>10.5预测PDAC预后不良,人工智能是预测PDAC预后的有效工具。
A non-invasive artificial intelligence model to predict the severity of intrapancreatic perineural invasion.
Introduction: Intrapancreatic perineural invasion (IPNI) was a poor prognostic factor in pancreatic ductal adenocarcinoma (PDAC), but few studies quantified the severity of IPNI. Additionally, there was an absence of non-invasive tool to predicted IPNI.
Methods: Patients who underwent radical pancreatectomy betweem 2018 and 2022 were enrolled. Severity of IPNI was assessed via binary classification, numeration, and neural invasion (NI) severity score. Cox regression analysis was performed to clarify the relationship between IPNI and prognosis. Clinical data, artificial intelligence (AI) , and radiomics were used to develop predictive models, evaluated by receiver operating characteristics (ROC) curve and decision curve analysis (DCA). Kaplan-Meier analysis confirmed the model's clinical utility.
Results: A total of 192 patients were enrolled and rate of IPNI was 93.8%. Cox regression analysis and ROC curve indicated NI severity score>10.5 was responsible for poor prognosis (p<0.05). Further analysis indicated the AI model had better performance in predicting NI severity score>10.5 in both training set (clinical model AUC=0.66, AI model AUC=0.85, radiomics model AUC=0.81) and validation set (clinical model AUC=0.74, AI model AUC=0.84, radiomics model AUC=0.73). According to the predictive results of AI model, patient with NI severity score>10.5 had decreased recurrence free survival(RFS) and overall survival(OS) in training set (RFS 12months vs. 24 months, p=0.002; OS 24 months vs. 35 months, p=0.024) and validation set (RFS 8 months vs. 16 months, p=0.03; OS 25 months vs. 36 months, p=0.04).
Conclusions: NI severity score >10.5 predicted poor PDAC prognosis, and AI was an useful tool to predict it.
期刊介绍:
''European Surgical Research'' features original clinical and experimental papers, condensed reviews of new knowledge relevant to surgical research, and short technical notes serving the information needs of investigators in various fields of operative medicine. Coverage includes surgery, surgical pathophysiology, drug usage, and new surgical techniques. Special consideration is given to information on the use of animal models, physiological and biological methods as well as biophysical measuring and recording systems. The journal is of particular value for workers interested in pathophysiologic concepts, new techniques and in how these can be introduced into clinical work or applied when critical decisions are made concerning the use of new procedures or drugs.